发明名称 |
NEW ORAL PHARMACEUTICAL DOSAGE FORM |
摘要 |
An oral pharmaceutical dosage form comprising an acid susceptible proton pump inhibitor and one or more antibacterial compounds in a fixed formulation. The fixed formulation is intended for oral use and in the form of an enteric coating layered tablet, a capsule or a multiple unit tableted dosage form. The multiple unit dosage form is most preferred. The new fixed formulation is especially useful in the treatment of disorders associated with Helicobacter infections.
|
申请公布号 |
CA2186039(A1) |
申请公布日期 |
1996.08.15 |
申请号 |
CA19962186039 |
申请日期 |
1996.02.02 |
申请人 |
ASTRA AKTIEBOLAG |
发明人 |
DEPUI, HELENE;ROSINSKI, ADAM |
分类号 |
A61K9/20;A61K;A61K9/22;A61K9/24;A61K9/26;A61K9/28;A61K9/48;A61K9/50;A61K9/52;A61K31/41;A61K31/415;A61K31/4164;A61K31/43;A61K31/431;A61K31/435;A61K31/44;A61K31/4439;A61K31/4545;A61K31/545;A61K31/70;A61K31/7048;A61K45/00;A61K45/06;A61P1/04;A61P31/04;C07D401/12;C07D403/12;C07D413/14;(IPC1-7):A61K31/71 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|